DEF: Princeton Capital Sets 2025 Annual Meeting Agenda

Sentiment:

Proxy Statement


Princeton Capital Corporation announces its 2025 Annual Meeting of Stockholders to address director elections, auditor ratification, and other corporate governance matters.

Delay expectedThe strategic review process, originally announced on November 15, 2019, remains active and ongoing as of August 19, 2021 (and reiterated in subsequent filings), indicating a prolonged period without resolution.The decision to keep a board vacancy unfilled since September 27, 2017, is tied to the completion of this ongoing strategic review process, implying a delay in achieving full board composition.

Summary

  • The 2025 Annual Meeting of Stockholders for Princeton Capital Corporation will be held on Thursday, December 18, 2025, at 2:00 p.m. Eastern Time in Baltimore, Maryland.
  • Stockholders of record at the close of business on November 11, 2025, are entitled to vote at the Annual Meeting.
  • Key proposals include the election of four directors, the ratification of WithumSmith&Brown, PC as the independent registered public accounting firm for the fiscal year ending December 31, 2025, and approval for adjournment if necessary to solicit additional proxies.
  • The Board of Directors, including the independent directors, recommends voting FOR each of these proposals.
  • Mark DiSalvo serves as Interim Chief Executive Officer and Interim President, and Gregory J. Cannella serves as Chief Financial Officer, Secretary, and Treasurer.
  • Capital Point Partners, LP and Capital Point Partners II, LP collectively beneficially own approximately 96% of the company's outstanding common stock.
  • The company's strategic review process, originally announced on November 15, 2019, remains active and ongoing, with updates provided quarterly in Form 10-Q and Form 10-K filings.
  • A board vacancy has existed since September 27, 2017, and the Board intends to review and consider filling it following the completion of the strategic review process.

Sentiment

Score: 5

Explanation: The filing is a routine proxy statement focused on corporate governance and annual meeting procedures. It contains no new financial performance data or significant strategic shifts, maintaining a neutral sentiment. The ongoing strategic review and board vacancy are existing disclosures.

Positives

  • The Board recommends FOR all proposals, indicating a stable and unified approach to routine governance matters.
  • Independent directors comprise a majority of the Board and all key committees (Audit, Nominating & Corporate Governance, Valuation), aligning with strong corporate governance practices.
  • All directors attended 100% of Board and committee meetings during 2024, demonstrating high engagement and oversight.
  • The company has established clear corporate governance guidelines, a Code of Business Conduct and Ethics, and a Statement on Prohibition of Insider Trading.
  • All Section 16(a) filing requirements for executive officers, directors, and greater than 10% beneficial owners were timely satisfied during the fiscal year ended December 31, 2024.

Negatives

  • A board vacancy has remained unfilled since September 27, 2017, pending the completion of a strategic review process that was initiated in November 2019 and is still ongoing, suggesting prolonged strategic uncertainty.
  • Mark DiSalvo, the Interim CEO, is an 'interested person' due to his control of the investment advisor (House Hanover) and significant beneficial ownership (95.85%) through related entities, which could raise potential conflict of interest considerations despite governance structures.
  • Independent directors do not receive any pension or retirement benefits, and the company does not have a stock or option plan, which might limit long-term alignment incentives for these key governance roles.

Risks

  • Strategic Review Process Uncertainty: The strategic review process, announced in November 2019, is still active and ongoing as of August 2021 (and reiterated in recent filings), indicating prolonged uncertainty regarding the company's future direction.
  • Board Vacancy: A board vacancy has existed since September 2017, with the decision to keep it open pending the strategic review, which could impact governance capacity or perception.
  • Concentrated Ownership: Capital Point Partners, LP and Capital Point Partners II, LP beneficially own approximately 96% of the company's common stock, leading to highly concentrated voting power.
  • Related Party Transactions: The Investment Advisory Agreement with House Hanover (controlled by Mr. DiSalvo) involves management fees and administration expense reimbursements, which are related party transactions requiring careful oversight.
  • Broker Non-Votes: Brokers cannot vote on director elections or adjournment proposals without specific instructions from beneficial owners, potentially impacting quorum or proposal approval if stockholders do not actively vote.

Future Outlook

The company's strategic review process, originally announced on November 15, 2019, remains active and ongoing. The Board and Nominating and Corporate Governance Committee intend to review and consider filling the existing board vacancy following the completion of this strategic review process.

Management Comments

  • "It is important that you be represented at the Annual Meeting, and you are encouraged to vote your shares as soon as possible." Mark DiSalvo, Interim Chief Executive Officer.
  • "Your vote is important." Mark DiSalvo, Interim Chief Executive Officer.
  • "The Board of Directors is not aware of any other matter to be properly presented for consideration at the Annual Meeting other than the matters set forth herein."
  • "The Board believes that its leadership structure is appropriate in light of our characteristics and circumstances because the structure allocates areas of responsibility among the individual directors and the committees in a manner that affords effective oversight."

Industry Context

Princeton Capital Corporation operates as a Business Development Company (BDC). The board members, particularly the independent directors, possess extensive experience in the offshore financial industry, hedge funds, fund of funds, and private equity, which is typical for a BDC's governance structure. The company's trading on the OTC Pink Limited Market suggests it may be a smaller or less liquid entity compared to those on major exchanges like NASDAQ, which is referenced for independence standards. The significant ownership by Capital Point Partners (96%) indicates a highly concentrated ownership structure, common in some private equity-backed or closely held BDCs.

Comparison to Industry Standards

  • The company's use of independent directors for all key committees (Audit, Nominating & Corporate Governance, Valuation) aligns with best practices for corporate governance, particularly for BDCs under the 1940 Act.
  • The board's determination that Mr. Laidlaw is an 'audit committee financial expert' meets SEC requirements for audit committee composition.
  • The compensation structure for independent directors, including annual fees and meeting fees, is a standard practice in the industry, though the cap of $50,000 per independent director annually might be on the lower side compared to larger, more complex BDCs.
  • The company's adherence to Section 16(a) filing requirements for executive officers and directors is a standard regulatory compliance expectation.
  • The highly concentrated ownership by Capital Point Partners (96%) is not typical for widely held public companies but can be seen in BDCs with strong sponsor backing, similar to private equity structures.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionThe Board consists of four directors (three independent, one interested), with one vacancy remaining unfilled since September 27, 2017, pending the strategic review process.OngoingThe prolonged vacancy may impact governance capacity or perception, but the Board intends to fill it post-strategic review.
Committee StructureEstablished Audit Committee, Nominating and Corporate Governance Committee, and Valuation Committee, all comprised solely of independent directors.OngoingEnhances independent oversight and aligns with strong corporate governance practices.
Leadership StructureIndependent director Darren Stainrod serves as Chairman of the Board. Mark DiSalvo serves as Interim CEO and Interim President.OngoingProvides an independent voice at the board leadership level while maintaining a bridge between the Board, investment advisor, and management.
Director IndependenceThe Board annually determines director independence based on NASDAQ rules and the 1940 Act, with Messrs. Stainrod, Laidlaw, and Bennett deemed independent.AnnuallyEnsures compliance with regulatory standards and promotes objective decision-making.
Code of EthicsThe company has a Code of Business Conduct and Ethics and Statement on the Prohibition of Insider Trading, requiring disclosure of conflicts of interest and review by the audit committee.OngoingPromotes ethical conduct and transparency, mitigating potential conflicts of interest.
Compensation CommitteeNo separate compensation committee; the Board (with Mr. DiSalvo recusing) makes decisions on advisor compensation, and the Nominating and Corporate Governance Committee reviews independent director compensation.OngoingCentralizes compensation decisions within the Board and independent committee, ensuring oversight.
Indemnification AgreementsEntered into with directors to provide maximum indemnification permitted by Maryland law and the 1940 Act.OngoingProtects directors from liabilities, potentially encouraging qualified individuals to serve on the Board.

Related Party Transactions

  • House Hanover, controlled by Mr. DiSalvo (Interim CEO), serves as the company's investment advisor under an Investment Advisory Agreement.
  • Management fees of $257,384 were accrued to House Hanover for the fiscal year ended December 31, 2024.
  • Administration expenses of $259,500 were accrued for House Hanover for the fiscal year ended December 31, 2024, for reimbursement of allocable compensation and costs.
  • Mr. DiSalvo, through Sema4, Inc., controls Capital Point Partners, LP and Capital Point Partners II, LP, which collectively own approximately 96% of the company's common stock.
  • The Audit Committee is responsible for conducting appropriate review and oversight of all related party transactions.

Stakeholder Impact

  • Shareholders: Will vote on key governance matters (director elections, auditor ratification). The highly concentrated ownership by Capital Point Partners (96%) means their vote will largely determine outcomes. The ongoing strategic review impacts future value.
  • Management/Employees: Executive officers are compensated by House Hanover, not directly by the company.
  • Auditors: WithumSmith&Brown, PC is proposed for ratification as the independent auditor for 2025.

Next Steps

  • Hold the 2025 Annual Meeting of Stockholders on December 18, 2025.
  • Stockholders to vote on the election of four directors.
  • Stockholders to vote on the ratification of WithumSmith&Brown, PC as the independent registered public accounting firm for 2025.
  • Stockholders to vote on the approval of adjournment of the Annual Meeting, if necessary, to solicit additional proxies.
  • The Board and Nominating and Corporate Governance Committee will review and consider filling the existing board vacancy following the completion of the strategic review process.
  • The strategic review process remains active and ongoing.

Key Dates

DateDescription
March 19, 2015Form 8-K filed with the SEC, including the company's Bylaws.
March 13, 2017Independent directors agreed to cap directors fees at $50,000 annually.
September 27, 2017Resignation of Mr. Munish Sood, creating a board vacancy.
January 1, 2018Interim Investment Advisory Agreement with House Hanover took effect.
May 30, 2018Interim Investment Advisory Agreement terminated.
May 31, 2018Investment Advisory Agreement with House Hanover took effect.
2018Investment Advisory Agreement approved by stockholders at the Annual Meeting.
November 15, 2019Strategic review process originally announced by the Board.
August 19, 2021Press release and Form 8-K filing stating the strategic review process remains active and ongoing.
December 31, 2023Fiscal year end for which audit fees were $149,136.
December 19, 2024Directors re-elected at the 2024 Annual Meeting of Stockholders.
December 31, 2024Fiscal year end for which audit fees were $169,520, and management/administration fees were accrued.
April 1, 2025Most recent Form 10-K filed with the SEC, incorporating Bylaws by reference.
August 13, 2025Most recent Form 10-Q filing updating on the strategic review process.
November 11, 2025Record date for stockholders entitled to notice of and to vote at the 2025 Annual Meeting.
November 12, 2025Date of the Dear Stockholder letter and Notice of Annual Meeting.
November 17, 2025Proxy statement, accompanying proxy card, and Annual Report on Form 10-K for 2024 first sent to stockholders.
December 18, 2025Date of the 2025 Annual Meeting of Stockholders.
July 15, 2026Deadline for stockholder proposals for inclusion in the 2026 proxy statement.
June 15, 2026Earliest date for stockholder nominations for the 2026 Annual Meeting.
2026Term expiration for directors elected at the 2025 Annual Meeting.

Recommendation

hold

This filing is a routine proxy statement for an annual meeting, primarily focused on corporate governance matters such as director elections and auditor ratification. It does not contain new financial performance data, significant strategic announcements, or other information that would typically drive a strong buy or sell recommendation. The ongoing strategic review process and board vacancy are existing disclosures, and while they represent long-term considerations, this specific filing does not introduce new catalysts for a change in investment stance. Therefore, a "hold" recommendation is appropriate as investors await further developments from the strategic review.

Keywords

Proxy Statement, Annual Meeting, Corporate Governance, Director Election, Independent Auditor, SEC Filing, Princeton Capital Corporation, Investment Company Act, Strategic Review, Shareholder Vote, Board of Directors, Audit Committee, Nominating and Corporate Governance Committee, Valuation Committee, Related Party Transactions, Business Development Company (BDC)

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.